Patients in the iPad-based Mobile Patient Technology for Health-CRC intervention, which included a decision aid and the ability to self-order tests, were twice as likely as patients in a control group to have a verified screening for colorectal cancer within 24 weeks, researchers reported in the Annals of Internal Medicine. Experts wrote in an accompanying editorial that it was difficult to discern what part of the trial drove the increase in screening.
Study finds mPATH-CRC intervention increases screenings
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.